Arkolith/Insider Trading/APRE/Form 4

Hamill John P.

SrVP/CFO/Prin Fin & Acct OfcrAprea Therapeutics, Inc. (APRE) · full profile →Form 4 · filed Oct 16, 2024
Net Buying
Open-Market Buys
$123
Open-Market Sells
$0
Net Open-Market Flow
$123
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 11, 2024Buy(P)50$2.46$12319K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-108962) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML